Abstract
Introduction

Leukaemia is one of the leading causes of cancer death worldwide. Although the current chemotherapy has remarkably improved the cure rate over the past decade, a number of patients still die of the disease. Drug resistance remains the major clinical obstacle to successful treatment of leukaemia patients and leads to poor prognosis compared to patients with relatively sensitive cells at the initial diagnosis [1]. Several studies have revealed that causes of cancer-specific drug resistance are linked to random druginduced mutational events (genetic hypothesis), drug-induced non-mutational alterations of gene function (epigenetic hypothesis) and drug-induced karyotypic changes (karyotypic hypothesis)
 [2] [3] [4] [5] 
. Some evidence suggests that the multiple drug resistance (MDR) protein 1 gene (MDR1) is activated during emerging resistance to anti-neoplastic drugs, resulting in overexpression of Pglycoprotein (P-gp), thus confers cancer cell resistance to a broad range of structurally and functionally diverse chemotherapeutic drugs, including drugs against leukaemia
. However promising diagnostic and prognostic markers in drug resistance/ sensitivity [9] [10] [11] . Yang et al. reported that miR-214 negatively regulated phosphatase and tensin homolog (PTEN) , which is a tumour suppressor, leading to induced cell survival and cisplatin resistance [12] . Xia et al. also showed that miR-15b and miR-16 modulated MDR by targeting BCL2 in human gastric cancer cells [13] . More recently, miR-451 and miR-326 were found to be inversely correlated with MDR1 and MDR-associated protein 1 (MRP1) expression in drug-resistant breast cancer cells [14, 15] . It was also reported that up-regulated miR-27a and miR-451 could stimulate MDR1 expression in cell lines of human ovarian cancer and cervix carcinoma [16] . However (Fig. 3C and D [24] and miRBase [25] yielded more than 30 miRNAs, including miR-331-5p and miR-27a (Fig. 4A,  upper panel) . Based on the bioinformatics analysis, we constructed a recombinant luciferase reporter system that combined a 3Ј-UTR segment of MDR1 with the putative miR-331-5p (Fig. 4A, lower 
Cell transfection
The miR-331-5p and miR-27a mimics were purchased from GenePharm (Shanghai, China). The three items of si-h-MDR1 were purchased from RiboBio (GuangZhou, China). Mimics or scrambled oligonucleotides (negative control, NC) were transfected into K562/DOX1, HL60/DOX and NB4/R2 cells at a final concentration of 100 nM, or 50 nM of miR-331-5p or miR-27a when co-transfected, and siRNAs (100 nM) were individually or combined transfected into K562/DOX1 cells using Lipofectamine 2000 (Invitrogen). The transfected cells were collected to exact RNA used for qRT-PCR or measure the protein levels of P-gp at 48 hrs after transfection.
Construction of the vector and luciferase reporter assay
Statistical analysis
Correlations were determined using Pearson correlation coefficient (r), and a Fisher r-to-z transformation was carried out to calculate a probability level (P-value). Student's t-test was performed to assay the statistical significance.
Results
Expression of P-gp in K562/WT and K562/DOX leukaemia cell lines
Red colour represents expression of P-gp and blue colour is the nuclear counter-stain. (B) Expression of P-gp gradually increases with the increased concentrations of DOX. K562/DOX1, K562/DOX2 and K562/DOX3. DOX-resistant cells were selected by prolonged treatment with 0.1 g/ml, 0.5 g /ml and 1 g/ml DOX, respectively. (C) Flow cytometry analysis of P-gp surface expression using the UIC2-phycoerythrin-conjugated antibody (filled red peak) and the corresponding IgG isotype control (clear peak). and miR-27a binding sites, psi-MDR1. Moreover, using the same system we made a psi-MDR1-M construct containing an miR-MRE with the miR-331-5p and miR-27a binding sites deleted
panel). The psi-MDR1 or psi-MDR1-M was co-transfected into cultured HEK-293T cells with miR-331-5p or miR-27a mimics.
As shown in Figure 4B ,
the transfection of miR-331-5p resulted in about 40% reduction of luciferase activity in the psi-MDR1-
Fig. 2 miRNA cluster analysis and qRT-PCR confirmation. (A) The top 83 differentially expressed miRNAs in the DOX-resistant cells. (1), (2) and (3) indicate three repeat array chips from each DOX-resistant cell line. Right upper panel: colour bar indicates fold changes of DOX-resistant cells versus K562/WT cells. The average miRNA expression of K562/WT cells was set as 1. (B, C) Selected miRNA expression was validated with qRT-PCR. (D, E) Expression of miR-27a and miR-331-5p were gradually down-regulated in the three DOX-resistant K562 cell lines compared to the sensitive cells. Error bars represent standard deviation and were obtained from three independent experiments *P Ͻ 0.05, compared with K562/WT cells. transfected HEK-293T cells. However, it did not affect reporter activity in the psi-MDR1-M-transfected HEK-293T cells. The luciferase activities showed almost no change in wild-type and mutant MDR1 reporter-transfected HEK-293T cells when miR-331-5p was deleted. Similar results were obtained when HEK-293T cells were transfected with miR-27a (Fig. 4B). These results suggest that MDR1 is a target of miR-331-5p and miR-27a and that the putative miR-331-5p and miR-27a binding sites are critical for regulating the expression of MDR1 by miR-331-5p and miR-27a. To elucidate whether miR-331-5p and miR-27a affect the protein levels of P-gp in K562 DOX-resistant cells, we transfected K562/DOX1 cells with miR-331-5p or/and miR-27a. P-gp expression was determined by Western blotting at 48 hrs after transfection. Figure 4C shows that transfection of K562-resistant cells with miR-27a or miR-331-5p, or a combination of miR-27a and miR-331-5p
, resulted in a decrease in P-gp levels. However, the combination of these two miRNAs had more inhibitory activity than any single miRNA.
Fig. 3 Expression of P-gp, miR-27a and miR-331-5p in sensitive and drug-resistant HL60 and NB4 cells.(A) Flow cytometry analysis of P-gp expression in HL60 and HL60/DOX cells. (B) Flow cytometry analysis of Pgp expression in NB4 and NB4/R2 cells. (C) Expression of miR-27a and miR-331-5p in HL60 and HL60/DOX cells using qRT-PCR. *P Ͻ 0.05, compared with HL60 cells. (D) Expression of miR-27a and miR-331-5p in NB4 and NB4/R2 cells using qRT-PCR. P Ͼ 0.05, compared with NB4 cells. Error bars represent standard deviation.
Fig. 4 Elevated levels of miR-27a and miR-331-5p, individually or in combination, inhibit expression of P-gp proteins in K562/DOX cells. (A) The putative miR-27a and miR-331-5p target sequence in the MDR1 gene. (B) Luciferase reporter assay in 293T cells. Expression of the MDR1 3Ј-UTR fragment, with the binding sequence for miR-27a and miR-331-5p, was inhibited by transfection of miR-27a (50 nM) and miR-331-5p (50 nM), respectively. The deleted region included the binding sites for miR-27a and miR-331-5p. (C) Protein expression levels of MDR1 in K562/DOX1 cells transfected with miR-27a and miR-331-5p, individually or in combination, were down-regulated compared to K562/DOX1 cells transfected with the scrambled oligonucleotides (NC). Error bars represent standard deviation.
Three independent experiments were performed.
MiR-331-5p and miR-27a are associated with relapse risk
It has been reported that P-gp expression is higher at relapse compared with the initial leukaemia or is related to the long-term survival or relapse risk [7] . (Fig. 6B) . Co-transfection of miR-331-5p and miR-27a significantly enhanced the sensitivity to DOX treatment in DOX-resistant leukaemia cells. The same result was found in HL60/DOX cells, whereas no effect was observed for the NB4/R2 cells which are resistant to ATRA (Fig. 7A-C) . This indicates a synergistic regulation mechanism of miR-331-5p and miR-27a in drug resistance. Fig. 6C) . Also, the results demonstrated that cell survival curves by overexpressing the miRNAs or by down-regulating MDR1 were closer to the parental cells (Fig. 6D) [27] [28] [29] [30] . Despite the wellestablished role of P-gp in leukaemia progression and drug resistance to chemotherapeutic drugs, the molecular mechanism for [38] . Gallardo et al. showed that miR-34a could be a prognostic marker of relapse in surgically resected non-small-cell lung cancer [39] . Patients with low miR-135a expression had a higher probability of relapse and a shorter disease-free survival in classic Hodgkin lymphoma [40] . Down 
MiR-331-5p and miR-27a can increase the sensitivity of K562/DOX and HL60/DOX cells to DOX
Reduced miR-331-5p and miR-27a expression in the drugresistant leukaemia cells and in the clinical samples from the
To further confirm that P-gp down-regulation is important for reversing the drug-resistance. RNAi against MDR1 was performed to analyse its role in drug sensitivity assay. The transfection of K562/DOX1 cells with different items of siRNAs against the MDR1 mRNA resulted in a strong decrease in the levels of the endogenous protein P-gp, especially for the two items of si-MDR1-1 and si-MDR1-3 (
